Futura Medical has announced Phase 3 data on its topical erectile dysfunction treatment MED3000, clearing the path for an FDA filing that could make the therapy an over-the-counter treatment option for erectile dysfunction. Phosphodiesterase type 5 inhibitors (PDE5is) such as Viagra (sildenafil) and Cialis (tadalafil) and generic equivalents currently dominate the erectile dysfunction market. Sildenafil and tadalafil…